Response to "What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation"

Biol Blood Marrow Transplant. 2013 Dec;19(12):1760-1. doi: 10.1016/j.bbmt.2013.10.005. Epub 2013 Oct 12.

Authors

Garrett S Booth¹, Eric A Gehrie, Bipin N Savani

Affiliation

¹ Vanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, Tennessee; Yale University, Department of Laboratory Medicine, New Haven, Connecticut; Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: garrett.s.booth@vanderbilt.edu.

PMID: 24125949
DOI: 10.1016/j.bbmt.2013.10.005

No abstract available

Publication types

Letter
Comment

MeSH terms

ABO Blood-Group System / immunology*
Blood Group Incompatibility / immunology*
Hematopoietic Stem Cell Transplantation / methods*
Humans

Substances

ABO Blood-Group System